Results Snapshot
Figures in Cr
Standalone - Profit And Loss Results
Mar'25
Mar'24
Mar'23
Profit And Loss Analysis Highlights
Net Sales
YoY Growth in year ended Mar 2025 is 150.47% vs -6.03% in Mar 2024
Operating Profit (PBDIT) excl Other Income
YoY Growth in year ended Mar 2025 is 170.15% vs 231.28% in Mar 2024
Interest
YoY Growth in year ended Mar 2025 is 23.74% vs 25.05% in Mar 2024
Profit After Tax
YoY Growth in year ended Mar 2025 is 292.00% vs 649.24% in Mar 2024
Compare Profit and Loss Results of Bio Medica Lab
Figures in Cr
standalone - Profit And Loss Results
Change(INR)
Change(%)
No of Months
12
12
Operating Income
38.00
193.00
-155.00
-80.31%
Less :Inter divisional transfers
0.00
0.00
0.00
0%
Less: Excise
0.00
0.00
0.00
0%
Net Sales
38.00
193.00
-155.00
-80.31%
Expenditure (Ex Depriciation)
Stock Adjustments
0.00
0.00
0.00
0%
Raw Materials Consumed
19.00
13.00
6.00
46.15%
Power & Fuel Cost
0.00
2.00
-2.00
-100.00%
Employee Cost
1.00
22.00
-21.00
-95.45%
Operating Expenses
0.00
0.00
0.00
0%
General and Administration Expenses
-1.00
-1.00
0.00
0.00%
Selling and Distribution Expenses
0.00
103.00
-103.00
-100.00%
Cost of Software developments
0.00
0.00
0.00
0%
Miscellaneous Expenses
0.00
1.00
-1.00
-100.00%
Expenses Capitalised
0.00
0.00
0.00
0%
Total Expenditure
22.00
169.00
-147.00
-86.98%
Operating Profit (PBDIT) excl Other Income
15.00
24.00
-9.00
-37.50%
Other Income
0.00
2.00
-2.00
-100.00%
Operating Profit (PBDIT)
15.00
27.00
-12.00
-44.44%
Interest
1.00
0.00
1.00
0%
Profit before Depriciation and Tax
14.00
26.00
-12.00
-46.15%
Depreciation
1.00
3.00
-2.00
-66.67%
Profit Before Taxation & Exceptional Items
13.00
23.00
-10.00
-43.48%
Exceptional Income / Expenses
0.00
0.00
0.00
0%
Profit Before Tax
13.00
23.00
-10.00
-43.48%
Provision for Tax
3.00
6.00
-3.00
-50.00%
Profit After Tax
9.00
17.00
-8.00
-47.06%
Extraordinary Items
0.00
0.00
0.00
0%
Adj to Profit After Tax
0.00
0.00
0.00
0%
Profit Balance B/F
4.00
9.00
-5.00
-55.56%
Profit Available for appropriations
14.00
26.00
-12.00
-46.15%
Appropriations
14.00
26.00
-12.00
-46.15%
Equity Dividend (%)
0%
7%
-7.00
Earnings Per Share
10.67
10.96
-0.29
-2.65%
Profit And Loss - Net Sales
Net Sales 38.20 Cr
in Mar 2025Figures in Cr
YoY Growth in year ended Mar 2025 is 150.47% vs -6.03% in Mar 2024
Profit And Loss - Operating Profit (PBDIT)
Operating Profit (PBDIT) 15.21 Cr
in Mar 2025Figures in Cr
YoY Growth in year ended Mar 2025 is 170.15% vs 231.28% in Mar 2024
Profit And Loss - Interest
Interest 1.20 Cr
in Mar 2025Figures in Cr
YoY Growth in year ended Mar 2025 is 23.74% vs 25.05% in Mar 2024
Profit And Loss - Profit After Tax
Profit After Tax 9.79 Cr
in Mar 2025Figures in Cr
YoY Growth in year ended Mar 2025 is 292.00% vs 649.24% in Mar 2024






